Pulmonary Alveolar Proteinosis Refractory to Plasmapheresis and Rituximab despite GM-CSF Antibody Reduction
We share our experience of a patient with pulmonary alveolar proteinosis who was refractory to plasmapheresis and rituximab despite a significant reduction in the offending antibody. He presented with shortness of breath, fevers, chills, and sweats for 4 months. He was diagnosed with autoimmune PAP...
Saved in:
| Main Authors: | Aysenur Keske, Eric M. Destrampe, Byron Barksdale, William N. Rose |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Case Reports in Immunology |
| Online Access: | http://dx.doi.org/10.1155/2022/2104270 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exogenous GM-CSF therapy for autoimmune pulmonary alveolar proteinosis: a systematic literature review
by: Wushu Chen, et al.
Published: (2025-05-01) -
Corrigendum: Exogenous GM-CSF therapy for autoimmune pulmonary alveolar proteinosis: a systematic literature review
by: Wushu Chen, et al.
Published: (2025-06-01) -
The Novel Use of Daratumumab in the Treatment of Refractory Autoimmune Pulmonary Alveolar Proteinosis
by: April Strong, et al.
Published: (2025-06-01) -
Primary pulmonary alveolar proteinosis
by: Šarac Sanja, et al.
Published: (2012-01-01) -
Congenital Pulmonary Alveolar Proteinosis
by: Saber Hammami, et al.
Published: (2013-01-01)